{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T06:53:03Z","timestamp":1777791183658,"version":"3.51.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"25","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2009,9,1]]},"DOI":"10.2174\/138161209789058165","type":"journal-article","created":{"date-parts":[[2009,8,21]],"date-time":"2009-08-21T01:49:27Z","timestamp":1250819367000},"page":"2915-2926","source":"Crossref","is-referenced-by-count":29,"title":["Contribution of Inflammatory Processes to Nerve Cell Toxicity by Bilirubin and Efficacy of Potential Therapeutic Agents"],"prefix":"10.2174","volume":"15","author":[{"given":"Adelaide","family":"Fernandes","sequence":"first","affiliation":[]},{"given":"Dora","family":"Brites","sequence":"additional","affiliation":[]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/69924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T13:46:23Z","timestamp":1448027183000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=15&issue=25&spage=2915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,1]]},"references-count":0,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2009,9,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/138161209789058165","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9,1]]}}}